When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs
Sara Volpe, Cosimo Tortorella, Vincenzo Solfrizzi, Giuseppina Piazzolla Interdisciplinary Department of Medicine, University of Bari “Aldo Moro” Medical School, Bari, 70124, ItalyCorrespondence: Giuseppina PiazzollaInterdisciplinary Department of Medicine, University of Bari “Aldo Moro” Medical Scho...
Enregistré dans:
Auteurs principaux: | Volpe S, Tortorella C, Solfrizzi V, Piazzolla G |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8a0096c139cf46d2a2a81c33a5c39f2c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion
par: Rouland A, et autres
Publié: (2021) -
Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
par: Courtney H, et autres
Publié: (2017) -
Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
par: Hwi Seung Kim, et autres
Publié: (2021) -
Efficacy and safety of dulaglutide in patients with absolute insulin deficiency
par: Kutoh Eiji, et autres
Publié: (2019) -
Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus
par: Almigbal TH
Publié: (2021)